A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Clinical trial NCT07215559 · RECRUITING

Trial details

NCT number: NCT07215559
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Overweight Diabetes Mellitus, Type 2

Start date: 2025-10-16
Primary completion: 2027-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.